SCHEMBL9129583

SCHEMBL9129583

COc1cc2c(cc1OC)C(CCCN1CCN(c3ccccn3)CC1)(c1ccc(F)cc1)OCC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.51
DRD3 P35462 7/20 0.51
DRD4 P21917 6/20 0.51
DRD2 P14416 8/20 0.48
HTR2A P28223 4/20 0.48
HTR7 P34969 4/20 0.48
ADRA2C P18825 3/20 0.48
DRD1 P21728 3/20 0.48
DRD5 P21918 3/20 0.48
HRH1 P35367 3/20 0.48
SIGMAR1 Q99720 7/20 0.47
ADRA1D P25100 2/20 0.46
ADRA1A P35348 2/20 0.46
ADRA1B P35368 2/20 0.46
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
HTR2C P28335 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9130259 0.88 SIGMAR1 (0.44) HTR1ADRD3DRD4DRD2HTR2A
SCHEMBL9134820 0.86 KDM4E (0.45) HTR1ADRD2HTR2AHTR7LMNA
SCHEMBL9131769 0.85 DRD2 (0.44) HTR1ADRD3DRD4DRD2HTR2A
SCHEMBL11668436 0.84 KMT2A (0.39) CYP1A2CYP2D6
SCHEMBL10752570 0.84 HTR1A (0.54) HTR1ADRD3DRD4DRD2HTR2A
SCHEMBL11674004 0.81 SIGMAR1 (0.42) HTR1ADRD3DRD4DRD2HTR7
SCHEMBL11072336 0.79 PARP1 (0.42) HTR1AHTR7SIGMAR1
SCHEMBL11224396 0.78 SLC6A4 (0.41) HTR1ADRD3HTR2ADRD1HRH1
SCHEMBL11223955 0.77 SLC6A4 (0.41) HTR1ADRD3HTR2ADRD1HRH1
SCHEMBL11071375 0.76 DRD2 (0.53) HTR1ADRD3DRD4DRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436337-A Anticarcinogenic agents THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0579754-A1 USE OF AMINES TO SENSITIZE MULTIDRUG-RESISTANT CELLS THE UPJOHN COMPANY (US) 1994-01-26 EP disclosed
WO-1992018089-A2 USE OF STEROIDAL AND NON-STEROIDAL AMINES TO SENSITIZE MULTIDRUG-RESISTANT CELLS THE UPJOHN COMPANY (US) 1992-10-29 WO disclosed